Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q89224170
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010742.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q89224170
|
035
|
|
|
‡a
(OCoLC)Q89224170
|
100
|
0 |
|
‡a
রিচার্ড কার্টার
‡9
bn
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Richard Carter
‡9
fr
‡9
nl
‡9
pt
‡9
sq
‡9
de
‡9
it
‡9
sv
‡9
pt-br
‡9
gl
‡9
es
|
400
|
0 |
|
‡a
Richard Carter
‡c
South African percussionist, composer and theatre director
‡9
en
|
670
|
|
|
‡a
Author's A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites
|
670
|
|
|
‡a
Author's A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum
|
670
|
|
|
‡a
Author's A malaria parasite toxin associated with Plasmodium vivax paroxysms
|
670
|
|
|
‡a
Author's A randomized, double-blind, placebo-controlled, clinical trial of the impact of malaria prevention on the educational attainment of school children
|
670
|
|
|
‡a
Author's A review. Innate resistance in malaria
|
670
|
|
|
‡a
Author's A single parasite gene determines strain-specific protective immunity against malaria: the role of the merozoite surface protein I.
|
670
|
|
|
‡a
Author's A stage specific gene expressed at the onset of gametocytogenesis in Plasmodium falciparum
|
670
|
|
|
‡a
Author's A study on pathogenicity and mosquito transmission success in the rodent malaria parasite Plasmodium chabaudi adami
|
670
|
|
|
‡a
Author's A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies.
|
670
|
|
|
‡a
Author's African origin of the malaria parasite Plasmodium vivax
|
670
|
|
|
‡a
Author's African Plasmodium vivax: distribution and origins
|
670
|
|
|
‡a
Author's Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages
|
670
|
|
|
‡a
Author's Amplified fragment length polymorphism measures proportions of malaria parasites carrying specific alleles in complex genetic mixtures
|
670
|
|
|
‡a
Author's An AFLP-based genetic linkage map of Plasmodium chabaudi chabaudi
|
670
|
|
|
‡a
Author's An electron microscopical study of the interaction of monoclonal antibodies with gametes of the malarial parasite Plasmodium gallinaceum
|
670
|
|
|
‡a
Author's An Electron Microscopical Study of the Interaction of Monoclonal Antibodies with Gametes of the Malarial Parasite Plasmodium gallinaceum1
|
670
|
|
|
‡a
Author's Anti-circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka
|
670
|
|
|
‡a
Author's Anti-gamete antibodies block transmission of human vivax malaria to mosquitoes
|
670
|
|
|
‡a
Author's Anti-gamete monoclonal antibodies synergistically block transmission of malaria by preventing fertilization in the mosquito
|
670
|
|
|
‡a
Author's Anti-parasite effects of cytokines in malaria
|
670
|
|
|
‡a
Author's Antibodies to plasmodium falciparum gamete surface antigens in papua new guinea sera
|
670
|
|
|
‡a
Author's Antigenic polymorphism in malaria: is it an important mechanism for immune evasion?
|
670
|
|
|
‡a
Author's Biochemical markers for strain differentiation in malarial parasites
|
670
|
|
|
‡a
Author's Biosynthesis of the target antigens of antibodies blocking transmission of Plasmodium falciparum
|
670
|
|
|
‡a
Author's Boosting of transmission-blocking immunity during natural Plasmodium vivax infections in humans depends upon frequent reinfection.
|
670
|
|
|
‡a
Author's Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies
|
670
|
|
|
‡a
Author's Characterization of a Plasmodium falciparium mutant that has deleted the majority of the gametocyte-specific Pf11-1 locus
|
670
|
|
|
‡a
Author's Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. I. Zygote surface antigens
|
670
|
|
|
‡a
Author's Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. II. Comparison of surface antigens of male and female gametes and zygotes
|
670
|
|
|
‡a
Author's Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. III. Changes in zygote surface proteins during transformation to mature ookinete
|
670
|
|
|
‡a
Author's Clinical disease and pathogenesis in malaria
|
670
|
|
|
‡a
Author's Clustering of malaria infections within an endemic population: risk of malaria associated with the type of housing construction
|
670
|
|
|
‡a
Author's Commitment of the malaria parasite Plasmodium falciparum to sexual and asexual development
|
670
|
|
|
‡a
Author's Commitment to sexual differentiation in the human malaria parasite, Plasmodium falciparum
|
670
|
|
|
‡a
Author's Complement effects of the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes. II. Changes in sensitivity to complement-like factors during zygote development
|
670
|
|
|
‡a
Author's Complement effects on the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes. I. Resistance of zygotes to the alternative pathway of complement
|
670
|
|
|
‡a
Author's Congenicity and genetic polymorphism in cloned lines derived from a single isolate of a rodent malaria parasite
|
670
|
|
|
‡a
Author's Conserved and Variant Epitopes of Target Antigens of Transmission-Blocking Antibodies among Isolates of Plasmodium falciparum from Malaysia
|
670
|
|
|
‡a
Author's Control of gamete formation
|
670
|
|
|
‡a
Author's Control of Gamete Formation (Exflagellation) in Malaria Parasites
|
670
|
|
|
‡a
Author's Current developments in malaria transmission-blocking vaccines
|
670
|
|
|
‡a
Author's Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates
|
670
|
|
|
‡a
Author's Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential
|
670
|
|
|
‡a
Author's Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease
|
670
|
|
|
‡a
Author's Detection of low level Plasmodium falciparum gametocytes using reverse transcriptase polymerase chain reaction
|
670
|
|
|
‡a
Author's Determinants on surface proteins of Plasmodium knowlesi merozoites common to Plasmodium falciparum schizonts
|
670
|
|
|
‡a
Author's Direct sequencing of enzymatically amplified DNA of alleles of the merozoite surface antigen MSA-1 gene from the malaria parasite Plasmodium falciparum
|
670
|
|
|
‡a
Author's DNA from pre-erythrocytic stage malaria parasites is detectable by PCR in the faeces and blood of hosts
|
670
|
|
|
‡a
Author's Drug Sensitivity and Isoenzyme Type in Cloned Lines of Plasmodium Falciparum
|
670
|
|
|
‡a
Author's Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria
|
670
|
|
|
‡a
Author's Effects of transmission-blocking monoclonal antibodies on different isolates of Plasmodium falciparum
|
670
|
|
|
‡a
Author's Enzyme variants in primate malaria parasites
|
670
|
|
|
‡a
Author's Epidemiological considerations for malaria reduction by transmission blocking vaccination
|
670
|
|
|
‡a
Author's Estimating SNP proportions in populations of malaria parasites by sequencing: validation and applications
|
670
|
|
|
‡a
Author's Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture
|
670
|
|
|
‡a
Author's Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa
|
670
|
|
|
‡a
Author's Evolutionary and Historical Aspects of the Burden of Malaria.
|
670
|
|
|
‡a
Author's Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing
|
670
|
|
|
‡a
Author's Frequency of cross-fertilization in the human malaria parasite Plasmodium falciparum
|
670
|
|
|
‡a
Author's G6PD gene variants and its association with malaria in a Sri Lankan population
|
670
|
|
|
‡a
Author's Gamete development in malaria parasites: bicarbonate-dependent stimulation by pH in vitro
|
670
|
|
|
‡a
Author's Gamete vaccines and transmission-blocking immunity in malaria
|
670
|
|
|
‡a
Author's Gametocytogenesis by malaria parasites in continuous culture
|
670
|
|
|
‡a
Author's Gametogenesis in culture by gametocytes of Plasmodium falciparum
|
670
|
|
|
‡a
Author's Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites
|
670
|
|
|
‡a
Author's Gene encoding erythrocyte binding ligand linked to blood stage multiplication rate phenotype in Plasmodium yoelii yoelii
|
670
|
|
|
‡a
Author's Gene synteny and chloroquine resistance in Plasmodium chabaudi
|
670
|
|
|
‡a
Author's Genetic analysis of the human malaria parasite plasmodium falciparum
|
670
|
|
|
‡a
Author's Genetic determinants of anti-malarial acquired immunity in a large multi-centre study
|
670
|
|
|
‡a
Author's Genetic hybrids of Plasmodium falciparum identified by amplification of genomic DNA from single oocysts
|
670
|
|
|
‡a
Author's Genetic Mapping of Virulence in Rodent Malarias
|
670
|
|
|
‡a
Author's Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka
|
670
|
|
|
‡a
Author's Genetic recombination in Plasmodium berghei
|
670
|
|
|
‡a
Author's Genetic structure of Plasmodium vivax isolates in India
|
670
|
|
|
‡a
Author's Genetic studies on Plasmodium chabaudi: recombination between enzyme markers
|
670
|
|
|
‡a
Author's High Frequency of Antibody Response to Plasmodium falciparum Gametocyte Antigens during Acute Malaria Infections in Papua New Guinea Highlanders
|
670
|
|
|
‡a
Author's HLA effects in malaria: increased parasite-killing immunity or reduced immunopathology?
|
670
|
|
|
‡a
Author's Host heterogeneity is a determinant of competitive exclusion or coexistence in genetically diverse malaria infections.
|
670
|
|
|
‡a
Author's Human antibody responses to Pfs 230, a sexual stage-specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated
|
670
|
|
|
‡a
Author's Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines
|
670
|
|
|
‡a
Author's Human T cell proliferative responses to Plasmodium vivax antigens: evidence of immunosuppression following prolonged exposure to endemic malaria
|
670
|
|
|
‡a
Author's Human T clones reactive to the sexual stages of plasmodium falciparum malaria. high frequency of gamete-reactive T cells in peripheral blood from nonexposed donors
|
670
|
|
|
‡a
Author's Immune responses against sexual stages of Plasmodium vivax during human malarial infections in Sri Lanka
|
670
|
|
|
‡a
Author's Immunity to Malarial Antigens on the Surface of Plasmodium falciparum-Infected Erythrocytes *
|
670
|
|
|
‡a
Author's Immunity to Sexual Stages of Malaria Parasites
|
670
|
|
|
‡a
Author's Infection of Aedes aegypti with zygotes of Plasmodium gallinaceum fertilized in vitro.
|
670
|
|
|
‡a
Author's Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka
|
670
|
|
|
‡a
Author's Infectivity of Plasmodium vivax and P. falciparum to Anopheles tessellatus; relationship between oocyst and sporozoite development
|
670
|
|
|
‡a
Author's Limited immunological recognition of critical malaria vaccine candidate antigens
|
670
|
|
|
‡a
Author's Linkage Group Selection--a fast approach to the genetic analysis of malaria parasites
|
670
|
|
|
‡a
Author's Linkage group selection: rapid gene discovery in malaria parasites
|
670
|
|
|
‡a
Author's Linkage group selection: towards identifying genes controlling strain specific protective immunity in malaria
|
670
|
|
|
‡a
Author's Linkage maps from multiple genetic crosses and loci linked to growth-related virulent phenotype in Plasmodium yoelii
|
670
|
|
|
‡a
Author's Malaria mortality rates in South Asia and in Africa: implications for malaria control
|
670
|
|
|
‡a
Author's Malaria parasites of rodents of the Congo (Brazzaville): Plasmodium chabaudi adami subsp. nov. and Plasmodium vinckei lentum Landau, Michel, Adam and Boulard, 1970
|
670
|
|
|
‡a
Author's Malaria risk factors in an endemic region of Sri Lanka, and the impact and cost implications of risk factor-based interventions
|
670
|
|
|
‡a
Author's Malaria transmission blocked by immunisation with gametes of the malaria parasite
|
670
|
|
|
‡a
Author's Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans
|
670
|
|
|
‡a
Author's Malaria transmission-blocking vaccines--how can their development be supported?
|
670
|
|
|
‡a
Author's Malaria transmission. Has the ignition key been found?
|
670
|
|
|
‡a
Author's Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua New Guinea
|
670
|
|
|
‡a
Author's Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines
|
670
|
|
|
‡a
Author's Measuring malaria.
|
670
|
|
|
‡a
Author's Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice
|
670
|
|
|
‡a
Author's Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria
|
670
|
|
|
‡a
Author's Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes
|
670
|
|
|
‡a
Author's New observations on gametogenesis, fertilization, and zygote transformation in Plasmodium gallinaceum
|
670
|
|
|
‡a
Author's New observations on the malaria parasites of rodents of the Central African Republic - Plasmodium vinckei petteri subsp. nov. and Plasmodium chabaudi Landau, 1965.
|
670
|
|
|
‡a
Author's New observations on the malaria parasites of rodents of the Central African Republic—Plasmodium vinckei petterisubsp. nov. andPlasmodium chabaudiLandau, 1965
|
670
|
|
|
‡a
Author's Numerous, robust genetic markers for Plasmodium chabaudi by the method of amplified fragment length polymorphism.
|
670
|
|
|
‡a
Author's Patterns of acquired anti-malarial immunity in Sri Lanka
|
670
|
|
|
‡a
Author's Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica
|
670
|
|
|
‡a
Author's Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka
|
670
|
|
|
‡a
Author's Plasmodium falciparum: parasites defective in early stages of gametocytogenesis
|
670
|
|
|
‡a
Author's Plasmodium gallinaceum: Induction of male gametocyte exflagellation by phosphodiesterase inhibitors
|
670
|
|
|
‡a
Author's Plasmodium gallinaceum: transmission-blocking immunity in chickens. I. Comparative immunogenicity of gametocyte- and gamete-containing preparations
|
670
|
|
|
‡a
Author's Plasmodium gallinaceum: Transmission-blocking immunity in chickens. II. The effect of antigamete antibodies in vitro and in vivo and their elaboration during infection
|
670
|
|
|
‡a
Author's Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity.
|
670
|
|
|
‡a
Author's Plasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation
|
670
|
|
|
‡a
Author's Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12.
|
670
|
|
|
‡a
Author's Proceedings: The passive transfer of immunity to Plasmodium berghei yoelii
|
670
|
|
|
‡a
Author's Proceedings: The T-cell response in murine malaria
|
670
|
|
|
‡a
Author's Properties of epitopes of pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of plasmodium falciparum
|
670
|
|
|
‡a
Author's Quantitative genome re-sequencing defines multiple mutations conferring chloroquine resistance in rodent malaria
|
670
|
|
|
‡a
Author's Quantitative Seq-LGS: Genome-Wide Identification of Genetic Drivers of Multiple Phenotypes in Malaria Parasites
|
670
|
|
|
‡a
Author's Radioiodination of parasite antigens with 1,3,4,6-tetrachloro-3 alpha, 6 alpha-diphenylglycoluril (IODOGEN): studies with zygotes of Plasmodium gallinaceum
|
670
|
|
|
‡a
Author's Rapid identification of genes controlling virulence and immunity in malaria parasites.
|
670
|
|
|
‡a
Author's Real-time quantitative PCR for analysis of genetically mixed infections of malaria parasites: technique validation and applications
|
670
|
|
|
‡a
Author's Research toward malaria vaccines
|
670
|
|
|
‡a
Author's Restricted or absent immune responses in human populations to plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies
|
670
|
|
|
‡a
Author's Sequence coding for a sexual stage specific protein of Plasmodium falciparum
|
670
|
|
|
‡a
Author's Severe vivax malaria: newly recognised or rediscovered
|
670
|
|
|
‡a
Author's Sexual differentiation in malaria parasites
|
670
|
|
|
‡a
Author's Spatial simulation of malaria transmission and its control by malaria transmission blocking vaccination
|
670
|
|
|
‡a
Author's Spatial targeting of interventions against malaria.
|
670
|
|
|
‡a
Author's Speculations on the origins of Plasmodium vivax malaria
|
670
|
|
|
‡a
Author's Strain-specific immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the rodent malaria parasite Plasmodium chabaudi
|
670
|
|
|
‡a
Author's Strain-specific protective effect of the immunity induced by live malarial sporozoites under chloroquine cover
|
670
|
|
|
‡a
Author's Strain specific protective immunity induced by pre-erythrocytic infection of toque monkeys with Plasmodium cynomolg.
|
670
|
|
|
‡a
Author's Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum
|
670
|
|
|
‡a
Author's Studies on enzyme variation in the murine malaria parasites Plasmodium berghei, P. yoelii, P. vinckei and P. chabaudi by starch gel electrophoresis
|
670
|
|
|
‡a
Author's Sudden increase in virulence in a strain of Plasmodium berghei yoelii.
|
670
|
|
|
‡a
Author's Sudden increase in virulence in a strain ofPlasmodium berghei yoelii
|
670
|
|
|
‡a
Author's Target antigens in malaria transmission blocking immunity
|
670
|
|
|
‡a
Author's Target antigens of malaria transmission blocking immunity.
|
670
|
|
|
‡a
Author's Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates
|
670
|
|
|
‡a
Author's Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum
|
670
|
|
|
‡a
Author's The 230-kDa gamete surface protein of plasmodium falciparum is also a target for transmission-blocking antibodies
|
670
|
|
|
‡a
Author's The culture and preparation of gametocytes of Plasmodium falciparum for immunochemical, molecular, and mosquito infectivity studies
|
670
|
|
|
‡a
Author's The cytoadherence linked asexual gene family of Plasmodium falciparum: are there roles other than cytoadherence?
|
670
|
|
|
‡a
Author's The distribution of enzyme variation in populations of Plasmodium falciparum in Africa
|
670
|
|
|
‡a
Author's The impact of repeated malaria attacks on the school performance of children
|
670
|
|
|
‡a
Author's The neglected burden of Plasmodium vivax malaria
|
670
|
|
|
‡a
Author's The origins of African Plasmodium vivax; insights from mitochondrial genome sequencing
|
670
|
|
|
‡a
Author's The paroxysm of Plasmodium vivax malaria
|
670
|
|
|
‡a
Author's The role of cytokines in Plasmodium vivax malaria
|
670
|
|
|
‡a
Author's Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms
|
670
|
|
|
‡a
Author's Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing
|
670
|
|
|
‡a
Author's Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka
|
670
|
|
|
‡a
Author's Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.
|
670
|
|
|
‡a
Author's Transmission blocking malaria vaccines
|
670
|
|
|
‡a
Author's Transmission immunity in malaria: reflections on the underlying immune mechanisms during natural infections and following artificial immunization
|
670
|
|
|
‡a
Author's Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients
|
670
|
|
|
‡a
Author's Two apparently nonrepeated epitopes on gametes of Plasmodium falciparum are targets of transmission-blocking antibodies
|
670
|
|
|
‡a
Author's Use of Synthetic Peptides in the Study of the Antibody Response to Plasmodium Vivax Sporozoites
|
670
|
|
|
‡a
Author's Validation of Pyrosequencing for accurate and high throughput estimation of allele frequencies in malaria parasites.
|
919
|
|
|
‡a
geneticstudiesonplasmodiumchabaudirecombinationbetweenenzymemarkers
‡A
Genetic studies on Plasmodium chabaudi: recombination between enzyme markers
‡9
1
|
919
|
|
|
‡a
geneticrecombinationinplasmodiumberghei
‡A
Genetic recombination in Plasmodium berghei
‡9
1
|
919
|
|
|
‡a
geneticstructureofplasmodiumvivaxisolatesinindia
‡A
Genetic structure of Plasmodium vivax isolates in India
‡9
1
|
919
|
|
|
‡a
linkagemapsfrommultiplegeneticcrossesandlocilinkedtogrowthrelatedvirulentphenotypeinplasmodiumyoelii
‡A
Linkage maps from multiple genetic crosses and loci linked to growth-related virulent phenotype in Plasmodium yoelii
‡9
1
|
919
|
|
|
‡a
directsequencingofenzymaticallyamplifieddnaofallelesofthemerozoitesurfaceantigenmsa1genefromthemalariaparasiteplasmodiumfalciparum
‡A
Direct sequencing of enzymatically amplified DNA of alleles of the merozoite surface antigen MSA-1 gene from the malaria parasite Plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
detectionoflowlevelplasmodiumfalciparumgametocytesusingreversetranscriptasepolymerasechainreaction
‡A
Detection of low level Plasmodium falciparum gametocytes using reverse transcriptase polymerase chain reaction
‡9
1
|
919
|
|
|
‡a
plasmodiumfalciparumparasitesdefectiveinearlystagesofgametocytogenesis
‡A
Plasmodium falciparum: parasites defective in early stages of gametocytogenesis
‡9
1
|
919
|
|
|
‡a
demonstrationofantidiseaseimmunitytoplasmodiumvivaxmalariainsrilankausingaquantitativemethodtoassessclinicaldisease
‡A
Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease
‡9
1
|
919
|
|
|
‡a
dnafrompreerythrocyticstagemalariaparasitesisdetectablebypcrinthefaecesandbloodofhosts
‡A
DNA from pre-erythrocytic stage malaria parasites is detectable by PCR in the faeces and blood of hosts
‡9
1
|
919
|
|
|
‡a
quantitativeseqlgsgenomewideidentificationofgeneticdriversofmultiplephenotypesinmalariaparasites
‡A
Quantitative Seq-LGS: Genome-Wide Identification of Genetic Drivers of Multiple Phenotypes in Malaria Parasites
‡9
1
|
919
|
|
|
‡a
radioiodinationofparasiteantigenswith1346tetrachloro3alpha6alphadiphenylglycoluriliodogenstudieswithzygotesofplasmodiumgallinaceum
‡A
Radioiodination of parasite antigens with 1,3,4,6-tetrachloro-3 alpha, 6 alpha-diphenylglycoluril (IODOGEN): studies with zygotes of Plasmodium gallinaceum
‡9
1
|
919
|
|
|
‡a
rapididentificationofgenescontrollingvirulenceandimmunityinmalariaparasites
‡A
Rapid identification of genes controlling virulence and immunity in malaria parasites.
‡9
1
|
919
|
|
|
‡a
realtimequantitativepcrforanalysisofgeneticallymixedinfectionsofmalariaparasitestechniquevalidationandapplications
‡A
Real-time quantitative PCR for analysis of genetically mixed infections of malaria parasites: technique validation and applications
‡9
1
|
919
|
|
|
‡a
researchtowardmalariavaccines
‡A
Research toward malaria vaccines
‡9
1
|
919
|
|
|
‡a
plasmodiumfalciparummalariatransmissionblockingimmunityunderconditionsoflowendemicityasinsrilanka
‡A
Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka
‡9
1
|
919
|
|
|
‡a
drugsensitivityandisoenzymetypeinclonedlinesofplasmodiumfalciparum
‡A
Drug Sensitivity and Isoenzyme Type in Cloned Lines of Plasmodium Falciparum
‡9
1
|
919
|
|
|
‡a
restrictedorabsentimmuneresponsesinhumanpopulationstoplasmodiumfalciparumgameteantigensthataretargetsofmalariatransmissionblockingantibodies
‡A
Restricted or absent immune responses in human populations to plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies
‡9
1
|
919
|
|
|
‡a
sequencecodingforasexualstagespecificproteinofplasmodiumfalciparum
‡A
Sequence coding for a sexual stage specific protein of Plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
plasmodiumcynomolgiserummediatedblockingandenhancementofinfectivitytomosquitoesduringinfectionsinthenaturalhostmacacasinica
‡A
Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica
‡9
1
|
919
|
|
|
‡a
severevivaxmalarianewlyrecognisedorrediscovered
‡A
Severe vivax malaria: newly recognised or rediscovered
‡9
1
|
919
|
|
|
‡a
malariamortalityratesinsouthasiaandinafricaimplicationsformalariacontrol
‡A
Malaria mortality rates in South Asia and in Africa: implications for malaria control
‡9
1
|
919
|
|
|
‡a
sexualdifferentiationinmalariaparasites
‡A
Sexual differentiation in malaria parasites
‡9
1
|
919
|
|
|
‡a
spatialsimulationofmalariatransmissionanditscontrolbymalariatransmissionblockingvaccination
‡A
Spatial simulation of malaria transmission and its control by malaria transmission blocking vaccination
‡9
1
|
919
|
|
|
‡a
spatialtargetingofinterventionsagainstmalaria
‡A
Spatial targeting of interventions against malaria.
‡9
1
|
919
|
|
|
‡a
speculationsontheoriginsofplasmodiumvivaxmalaria
‡A
Speculations on the origins of Plasmodium vivax malaria
‡9
1
|
919
|
|
|
‡a
dynamicsoffeverandserumlevelsoftumornecrosisfactorarecloselyassociatedduringclinicalparoxysmsinplasmodiumvivaxmalaria
‡A
Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria
‡9
1
|
919
|
|
|
‡a
plasmodiumgallinaceuminductionofmalegametocyteexflagellationbyphosphodiesteraseinhibitors
‡A
Plasmodium gallinaceum: Induction of male gametocyte exflagellation by phosphodiesterase inhibitors
‡9
1
|
919
|
|
|
‡a
effectsoftransmissionblockingmonoclonalantibodiesondifferentisolatesofplasmodiumfalciparum
‡A
Effects of transmission-blocking monoclonal antibodies on different isolates of Plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
enzymevariantsinprimatemalariaparasites
‡A
Enzyme variants in primate malaria parasites
‡9
1
|
919
|
|
|
‡a
malariaparasitesofrodentsofthecongobrazzavilleplasmodiumchabaudiadamisubspnovandplasmodiumvinckeilentumlandaumicheladamandboulard
‡A
Malaria parasites of rodents of the Congo (Brazzaville): Plasmodium chabaudi adami subsp. nov. and Plasmodium vinckei lentum Landau, Michel, Adam and Boulard, 1970
‡9
1
|
919
|
|
|
‡a
cytokineskillmalariaparasitesduringinfectioncrisisextracellularcomplementaryfactorsareessential
‡A
Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential
‡9
1
|
919
|
|
|
‡a
cytokinemediatedinactivationofmalarialgametocytesisdependentonthepresenceofwhitebloodcellsandinvolvesreactivenitrogenintermediates
‡A
Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates
‡9
1
|
919
|
|
|
‡a
currentdevelopmentsinmalariatransmissionblockingvaccines
‡A
Current developments in malaria transmission-blocking vaccines
‡9
1
|
919
|
|
|
‡a
controlofgameteformationexflagellationinmalariaparasites
‡A
Control of Gamete Formation (Exflagellation) in Malaria Parasites
‡9
1
|
919
|
|
|
‡a
controlofgameteformation
‡A
Control of gamete formation
‡9
1
|
919
|
|
|
‡a
conservedandvariantepitopesoftargetantigensoftransmissionblockingantibodiesamongisolatesofplasmodiumfalciparumfrommalaysia
‡A
Conserved and Variant Epitopes of Target Antigens of Transmission-Blocking Antibodies among Isolates of Plasmodium falciparum from Malaysia
‡9
1
|
919
|
|
|
‡a
epidemiologicalconsiderationsformalariareductionbytransmissionblockingvaccination
‡A
Epidemiological considerations for malaria reduction by transmission blocking vaccination
‡9
1
|
919
|
|
|
‡a
linkagegroupselectiontowardsidentifyinggenescontrollingstrainspecificprotectiveimmunityinmalaria
‡A
Linkage group selection: towards identifying genes controlling strain specific protective immunity in malaria
‡9
1
|
919
|
|
|
‡a
linkagegroupselectionrapidgenediscoveryinmalariaparasites
‡A
Linkage group selection: rapid gene discovery in malaria parasites
‡9
1
|
919
|
|
|
‡a
malariariskfactorsinanendemicregionofsrilankaandtheimpactandcostimplicationsofriskfactorbasedinterventions
‡A
Malaria risk factors in an endemic region of Sri Lanka, and the impact and cost implications of risk factor-based interventions
‡9
1
|
919
|
|
|
‡a
malariatransmissionblockedbyimmunisationwithgametesofthemalariaparasite
‡A
Malaria transmission blocked by immunisation with gametes of the malaria parasite
‡9
1
|
919
|
|
|
‡a
linkagegroupselectionafastapproachtothegeneticanalysisofmalariaparasites
‡A
Linkage Group Selection--a fast approach to the genetic analysis of malaria parasites
‡9
1
|
919
|
|
|
‡a
limitedimmunologicalrecognitionofcriticalmalariavaccinecandidateantigens
‡A
Limited immunological recognition of critical malaria vaccine candidate antigens
‡9
1
|
919
|
|
|
‡a
patternsofacquiredantimalarialimmunityinsrilanka
‡A
Patterns of acquired anti-malarial immunity in Sri Lanka
‡9
1
|
919
|
|
|
‡a
strainspecificimmunitymaydriveadaptivepolymorphisminthemerozoitesurfaceprotein1oftherodentmalariaparasiteplasmodiumchabaudi
‡A
Strain-specific immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the rodent malaria parasite Plasmodium chabaudi
‡9
1
|
919
|
|
|
‡a
strainspecificprotectiveeffectoftheimmunityinducedbylivemalarialsporozoitesunderchloroquinecover
‡A
Strain-specific protective effect of the immunity induced by live malarial sporozoites under chloroquine cover
‡9
1
|
919
|
|
|
‡a
strainspecificprotectiveimmunityinducedbypreerythrocyticinfectionoftoquemonkeyswithplasmodiumcynomolg
‡A
Strain specific protective immunity induced by pre-erythrocytic infection of toque monkeys with Plasmodium cynomolg.
‡9
1
|
919
|
|
|
‡a
structuralmodelsfortheproteinfamilycharacterizedbygametesurfaceproteinpfs230ofplasmodiumfalciparum
‡A
Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
studiesonenzymevariationinthemurinemalariaparasitesplasmodiumbergheipyoeliipvinckeiandpchabaudibystarchgelelectrophoresis
‡A
Studies on enzyme variation in the murine malaria parasites Plasmodium berghei, P. yoelii, P. vinckei and P. chabaudi by starch gel electrophoresis
‡9
1
|
919
|
|
|
‡a
suddenincreaseinvirulenceinastrainofplasmodiumbergheiyoelii
‡A
Sudden increase in virulence in a strain of Plasmodium berghei yoelii.
‡9
2
|
919
|
|
|
‡a
plasmodiumgallinaceumtransmissionblockingimmunityinchickens1comparativeimmunogenicityofgametocyteandgametecontainingpreparations
‡A
Plasmodium gallinaceum: transmission-blocking immunity in chickens. I. Comparative immunogenicity of gametocyte- and gamete-containing preparations
‡9
1
|
919
|
|
|
‡a
plasmodiumgallinaceumtransmissionblockingimmunityinchickens2theeffectofantigameteantibodiesinvitroandinvivoandtheirelaborationduringinfection
‡A
Plasmodium gallinaceum: Transmission-blocking immunity in chickens. II. The effect of antigamete antibodies in vitro and in vivo and their elaboration during infection
‡9
1
|
919
|
|
|
‡a
congenicityandgeneticpolymorphisminclonedlinesderivedfromasingleisolateofarodentmalariaparasite
‡A
Congenicity and genetic polymorphism in cloned lines derived from a single isolate of a rodent malaria parasite
‡9
1
|
919
|
|
|
‡a
plasmodiumvivaxparoxysmassociatedlipidsmediateleukocyteaggregation
‡A
Plasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation
‡9
1
|
919
|
|
|
‡a
determinantsonsurfaceproteinsofplasmodiumknowlesimerozoitescommontoplasmodiumfalciparumschizonts
‡A
Determinants on surface proteins of Plasmodium knowlesi merozoites common to Plasmodium falciparum schizonts
‡9
1
|
919
|
|
|
‡a
predicteddisulfidebondedstructuresfor3uniquelyrelatedproteinsofplasmodiumfalciparumpfs230pfs4845andpf12
‡A
Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12.
‡9
1
|
919
|
|
|
‡a
plasmodiumvivaxmalariainsrilankatransmissiondiseaseandimmunity
‡A
Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity.
‡9
1
|
919
|
|
|
‡a
complementeffectsontheinfectivityofplasmodiumgallinaceumtoaedesaegyptimosquitoes1resistanceofzygotestothealternativepathwayofcomplement
‡A
Complement effects on the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes. I. Resistance of zygotes to the alternative pathway of complement
‡9
1
|
919
|
|
|
‡a
complementeffectsoftheinfectivityofplasmodiumgallinaceumtoaedesaegyptimosquitoes2changesinsensitivitytocomplementlikefactorsduringzygotedevelopment
‡A
Complement effects of the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes. II. Changes in sensitivity to complement-like factors during zygote development
‡9
1
|
919
|
|
|
‡a
commitmenttosexualdifferentiationinthehumanmalariaparasiteplasmodiumfalciparum
‡A
Commitment to sexual differentiation in the human malaria parasite, Plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
infectivityofplasmodiumvivaxandpfalciparumtoanophelestessellatusrelationshipbetweenoocystandsporozoitedevelopment
‡A
Infectivity of Plasmodium vivax and P. falciparum to Anopheles tessellatus; relationship between oocyst and sporozoite development
‡9
1
|
919
|
|
|
‡a
infectiousreservoirofplasmodiumvivaxandplasmodiumfalciparummalariainanendemicregionofsrilanka
‡A
Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka
‡9
1
|
919
|
|
|
‡a
infectionofaedesaegyptiwithzygotesofplasmodiumgallinaceumfertilizedinvitro
‡A
Infection of Aedes aegypti with zygotes of Plasmodium gallinaceum fertilized in vitro.
‡9
1
|
919
|
|
|
‡a
immunitytosexualstagesofmalariaparasites
‡A
Immunity to Sexual Stages of Malaria Parasites
‡9
1
|
919
|
|
|
‡a
validationofpyrosequencingforaccurateandhighthroughputestimationofallelefrequenciesinmalariaparasites
‡A
Validation of Pyrosequencing for accurate and high throughput estimation of allele frequencies in malaria parasites.
‡9
1
|
919
|
|
|
‡a
useofsyntheticpeptidesinthestudyoftheantibodyresponsetoplasmodiumvivaxsporozoites
‡A
Use of Synthetic Peptides in the Study of the Antibody Response to Plasmodium Vivax Sporozoites
‡9
1
|
919
|
|
|
‡a
2apparentlynonrepeatedepitopesongametesofplasmodiumfalciparumaretargetsoftransmissionblockingantibodies
‡A
Two apparently nonrepeated epitopes on gametes of Plasmodium falciparum are targets of transmission-blocking antibodies
‡9
1
|
919
|
|
|
‡a
tumournecrosisfactordependentparasitekillingeffectsduringparoxysmsinnonimmuneplasmodiumvivaxmalariapatients
‡A
Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients
‡9
1
|
919
|
|
|
‡a
immunitytomalarialantigensonthesurfaceofplasmodiumfalciparuminfectederythrocytes
‡A
Immunity to Malarial Antigens on the Surface of Plasmodium falciparum-Infected Erythrocytes *
‡9
1
|
919
|
|
|
‡a
transmissionimmunityinmalariareflectionsontheunderlyingimmunemechanismsduringnaturalinfectionsandfollowingartificialimmunization
‡A
Transmission immunity in malaria: reflections on the underlying immune mechanisms during natural infections and following artificial immunization
‡9
1
|
919
|
|
|
‡a
malariatransmissionblockingimmunityinducedbynaturalinfectionsofplasmodiumvivaxinhumans
‡A
Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans
‡9
1
|
919
|
|
|
‡a
commitmentofthemalariaparasiteplasmodiumfalciparumtosexualandasexualdevelopment
‡A
Commitment of the malaria parasite Plasmodium falciparum to sexual and asexual development
‡9
1
|
919
|
|
|
‡a
clusteringofmalariainfectionswithinanendemicpopulationriskofmalariaassociatedwiththetypeofhousingconstruction
‡A
Clustering of malaria infections within an endemic population: risk of malaria associated with the type of housing construction
‡9
1
|
919
|
|
|
‡a
transmissionblockingmalariavaccines
‡A
Transmission blocking malaria vaccines
‡9
1
|
919
|
|
|
‡a
transmissionblockingimmunitytoplasmodiumfalciparuminmalariaimmuneindividualsisassociatedwithantibodiestothegametesurfaceproteinpfs230
‡A
Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.
‡9
1
|
919
|
|
|
‡a
clinicaldiseaseandpathogenesisinmalaria
‡A
Clinical disease and pathogenesis in malaria
‡9
1
|
919
|
|
|
‡a
characterizationofantigensonmosquitomidgutstagesofplasmodiumgallinaceum3changesinzygotesurfaceproteinsduringtransformationtomatureookinete
‡A
Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. III. Changes in zygote surface proteins during transformation to mature ookinete
‡9
1
|
919
|
|
|
‡a
characterizationofantigensonmosquitomidgutstagesofplasmodiumgallinaceum2comparisonofsurfaceantigensofmaleandfemalegametesandzygotes
‡A
Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. II. Comparison of surface antigens of male and female gametes and zygotes
‡9
1
|
919
|
|
|
‡a
characterizationofantigensonmosquitomidgutstagesofplasmodiumgallinaceum1zygotesurfaceantigens
‡A
Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. I. Zygote surface antigens
‡9
1
|
919
|
|
|
‡a
characterizationofaplasmodiumfalcipariummutantthathasdeletedthemajorityofthegametocytespecificpf111locus
‡A
Characterization of a Plasmodium falciparium mutant that has deleted the majority of the gametocyte-specific Pf11-1 locus
‡9
1
|
919
|
|
|
‡a
characteristicsofmalariatransmissioninkataragamasrilankaafocusforimmunoepidemiologicalstudies
‡A
Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies
‡9
1
|
919
|
|
|
‡a
boostingoftransmissionblockingimmunityduringnaturalplasmodiumvivaxinfectionsinhumansdependsuponfrequentreinfection
‡A
Boosting of transmission-blocking immunity during natural Plasmodium vivax infections in humans depends upon frequent reinfection.
‡9
1
|
919
|
|
|
‡a
biosynthesisofthetargetantigensofantibodiesblockingtransmissionofplasmodiumfalciparum
‡A
Biosynthesis of the target antigens of antibodies blocking transmission of Plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
biochemicalmarkersforstraindifferentiationinmalarialparasites
‡A
Biochemical markers for strain differentiation in malarial parasites
‡9
1
|
919
|
|
|
‡a
antigenicpolymorphisminmalariaisitanimportantmechanismforimmuneevasion
‡A
Antigenic polymorphism in malaria: is it an important mechanism for immune evasion?
‡9
1
|
919
|
|
|
‡a
antibodiestoplasmodiumfalciparumgametesurfaceantigensinpapuanewguineasera
‡A
Antibodies to plasmodium falciparum gamete surface antigens in papua new guinea sera
‡9
1
|
919
|
|
|
‡a
antiparasiteeffectsofcytokinesinmalaria
‡A
Anti-parasite effects of cytokines in malaria
‡9
1
|
919
|
|
|
‡a
antigametemonoclonalantibodiessynergisticallyblocktransmissionofmalariabypreventingfertilizationinthemosquito
‡A
Anti-gamete monoclonal antibodies synergistically block transmission of malaria by preventing fertilization in the mosquito
‡9
1
|
919
|
|
|
‡a
antigameteantibodiesblocktransmissionofhumanvivaxmalariatomosquitoes
‡A
Anti-gamete antibodies block transmission of human vivax malaria to mosquitoes
‡9
1
|
919
|
|
|
‡a
transmissionblockingimmunitytohumanplasmodiumvivaxmalariainanendemicpopulationinkataragamasrilanka
‡A
Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka
‡9
1
|
919
|
|
|
‡a
transmissionblockingantibodiesagainstmultiplenonvarianttargetepitopesoftheplasmodiumfalciparumgametesurfaceantigenpfs230areallcomplementfixing
‡A
Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing
‡9
1
|
919
|
|
|
‡a
transientincreaseincirculatinggammadeltatcellsduringplasmodiumvivaxmalarialparoxysms
‡A
Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms
‡9
1
|
919
|
|
|
‡a
roleofcytokinesinplasmodiumvivaxmalaria
‡A
The role of cytokines in Plasmodium vivax malaria
‡9
1
|
919
|
|
|
‡a
paroxysmofplasmodiumvivaxmalaria
‡A
The paroxysm of Plasmodium vivax malaria
‡9
1
|
919
|
|
|
‡a
originsofafricanplasmodiumvivaxinsightsfrommitochondrialgenomesequencing
‡A
The origins of African Plasmodium vivax; insights from mitochondrial genome sequencing
‡9
1
|
919
|
|
|
‡a
anticircumsporozoiteproteinantibodiesmeasureagerelatedexposuretomalariainkataragamasrilanka
‡A
Anti-circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka
‡9
1
|
919
|
|
|
‡a
electronmicroscopicalstudyoftheinteractionofmonoclonalantibodieswithgametesofthemalarialparasiteplasmodiumgallinaceum1
‡A
An Electron Microscopical Study of the Interaction of Monoclonal Antibodies with Gametes of the Malarial Parasite Plasmodium gallinaceum1
‡9
1
|
919
|
|
|
‡a
electronmicroscopicalstudyoftheinteractionofmonoclonalantibodieswithgametesofthemalarialparasiteplasmodiumgallinaceum
‡A
An electron microscopical study of the interaction of monoclonal antibodies with gametes of the malarial parasite Plasmodium gallinaceum
‡9
1
|
919
|
|
|
‡a
aflpbasedgeneticlinkagemapofplasmodiumchabaudichabaudi
‡A
An AFLP-based genetic linkage map of Plasmodium chabaudi chabaudi
‡9
1
|
919
|
|
|
‡a
amplifiedfragmentlengthpolymorphismmeasuresproportionsofmalariaparasitescarryingspecificallelesincomplexgeneticmixtures
‡A
Amplified fragment length polymorphism measures proportions of malaria parasites carrying specific alleles in complex genetic mixtures
‡9
1
|
919
|
|
|
‡a
allelicformsofgp195amajorbloodstageantigenofplasmodiumfalciparumareexpressedinliverstages
‡A
Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages
‡9
1
|
919
|
|
|
‡a
numerousrobustgeneticmarkersforplasmodiumchabaudibythemethodofamplifiedfragmentlengthpolymorphism
‡A
Numerous, robust genetic markers for Plasmodium chabaudi by the method of amplified fragment length polymorphism.
‡9
1
|
919
|
|
|
‡a
newobservationsonthemalariaparasitesofrodentsofthecentralafricanrepublicplasmodiumvinckeipetterisubspnovandplasmodiumchabaudilandau
‡A
New observations on the malaria parasites of rodents of the Central African Republic—Plasmodium vinckei petterisubsp. nov. andPlasmodium chabaudiLandau, 1965
‡9
2
|
919
|
|
|
‡a
malariatransmissionblockingvaccineshowcantheirdevelopmentbesupported
‡A
Malaria transmission-blocking vaccines--how can their development be supported?
‡9
1
|
919
|
|
|
‡a
malariatransmissionhastheignitionkeybeenfound
‡A
Malaria transmission. Has the ignition key been found?
‡9
1
|
919
|
|
|
‡a
targetantigensinmalariatransmissionblockingimmunity
‡A
Target antigens in malaria transmission blocking immunity
‡9
1
|
919
|
|
|
‡a
targetantigensofmalariatransmissionblockingimmunity
‡A
Target antigens of malaria transmission blocking immunity.
‡9
1
|
919
|
|
|
‡a
proceedingsthepassivetransferofimmunitytoplasmodiumbergheiyoelii
‡A
Proceedings: The passive transfer of immunity to Plasmodium berghei yoelii
‡9
1
|
919
|
|
|
‡a
immuneresponsesagainstsexualstagesofplasmodiumvivaxduringhumanmalarialinfectionsinsrilanka
‡A
Immune responses against sexual stages of Plasmodium vivax during human malarial infections in Sri Lanka
‡9
1
|
919
|
|
|
‡a
humantclonesreactivetothesexualstagesofplasmodiumfalciparummalariahighfrequencyofgametereactivetcellsinperipheralbloodfromnonexposeddonors
‡A
Human T clones reactive to the sexual stages of plasmodium falciparum malaria. high frequency of gamete-reactive T cells in peripheral blood from nonexposed donors
‡9
1
|
919
|
|
|
‡a
estimatingsnpproportionsinpopulationsofmalariaparasitesbysequencingvalidationandapplications
‡A
Estimating SNP proportions in populations of malaria parasites by sequencing: validation and applications
‡9
1
|
919
|
|
|
‡a
evidenceforenvironmentalmodulationofgametocytogenesisinplasmodiumfalciparumincontinuousculture
‡A
Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture
‡9
1
|
919
|
|
|
‡a
newobservationsongametogenesisfertilizationandzygotetransformationinplasmodiumgallinaceum
‡A
New observations on gametogenesis, fertilization, and zygote transformation in Plasmodium gallinaceum
‡9
1
|
919
|
|
|
‡a
proceedingsthetcellresponseinmurinemalaria
‡A
Proceedings: The T-cell response in murine malaria
‡9
1
|
919
|
|
|
‡a
evidenceforthetransmissionofplasmodiumvivaxintherepublicofthecongowestcentralafrica
‡A
Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa
‡9
1
|
919
|
|
|
‡a
evolutionaryandhistoricalaspectsoftheburdenofmalaria
‡A
Evolutionary and Historical Aspects of the Burden of Malaria.
‡9
1
|
919
|
|
|
‡a
measurementofmalarialinfectivityofhumanpopulationstomosquitoesinthemadangareapapuanewguinea
‡A
Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua New Guinea
‡9
1
|
919
|
|
|
‡a
failuretodetectplasmodiumvivaxinwestandcentralafricabypcrspeciestyping
‡A
Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing
‡9
1
|
919
|
|
|
‡a
measurementofplasmodiumfalciparumgrowthratesinvivoatestofmalariavaccines
‡A
Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines
‡9
1
|
919
|
|
|
‡a
measuringmalaria
‡A
Measuring malaria.
‡9
1
|
919
|
|
|
‡a
mixedstraininfectionsandstrainspecificprotectiveimmunityintherodentmalariaparasiteplasmodiumchabaudichabaudiinmice
‡A
Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice
‡9
1
|
919
|
|
|
‡a
monoclonalandpolyclonalantibodiesbothblockandenhancetransmissionofhumanplasmodiumvivaxmalaria
‡A
Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria
‡9
1
|
919
|
|
|
‡a
frequencyofcrossfertilizationinthehumanmalariaparasiteplasmodiumfalciparum
‡A
Frequency of cross-fertilization in the human malaria parasite Plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
g6pdgenevariantsanditsassociationwithmalariainasrilankanpopulation
‡A
G6PD gene variants and its association with malaria in a Sri Lankan population
‡9
1
|
919
|
|
|
‡a
targetantigensoftransmissionblockingimmunityofplasmodiumvivaxmalariacharacterizationandpolymorphisminnaturalparasiteisolates
‡A
Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates
‡9
1
|
919
|
|
|
‡a
targetantigensoftransmissionblockingimmunityongametesofplasmodiumfalciparum
‡A
Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
monoclonalantibodiesagainstsurfacedeterminantsongametesofplasmodiumgallinaceumblocktransmissionofmalariaparasitestomosquitoes
‡A
Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes
‡9
1
|
919
|
|
|
‡a
gametedevelopmentinmalariaparasitesbicarbonatedependentstimulationbyphinvitro
‡A
Gamete development in malaria parasites: bicarbonate-dependent stimulation by pH in vitro
‡9
1
|
919
|
|
|
‡a
gametevaccinesandtransmissionblockingimmunityinmalaria
‡A
Gamete vaccines and transmission-blocking immunity in malaria
‡9
1
|
919
|
|
|
‡a
gametocytogenesisbymalariaparasitesincontinuousculture
‡A
Gametocytogenesis by malaria parasites in continuous culture
‡9
1
|
919
|
|
|
‡a
africanplasmodiumvivaxdistributionandorigins
‡A
African Plasmodium vivax: distribution and origins
‡9
1
|
919
|
|
|
‡a
africanoriginofthemalariaparasiteplasmodiumvivax
‡A
African origin of the malaria parasite Plasmodium vivax
‡9
1
|
919
|
|
|
‡a
surfaceproteinexpressedduringthetransformationofzygotesofplasmodiumgallinaceumisatargetoftransmissionblockingantibodies
‡A
A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies.
‡9
1
|
919
|
|
|
‡a
studyonpathogenicityandmosquitotransmissionsuccessintherodentmalariaparasiteplasmodiumchabaudiadami
‡A
A study on pathogenicity and mosquito transmission success in the rodent malaria parasite Plasmodium chabaudi adami
‡9
1
|
919
|
|
|
‡a
stagespecificgeneexpressedattheonsetofgametocytogenesisinplasmodiumfalciparum
‡A
A stage specific gene expressed at the onset of gametocytogenesis in Plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
singleparasitegenedeterminesstrainspecificprotectiveimmunityagainstmalariatheroleofthemerozoitesurfaceprotein1
‡A
A single parasite gene determines strain-specific protective immunity against malaria: the role of the merozoite surface protein I.
‡9
1
|
919
|
|
|
‡a
230kdagametesurfaceproteinofplasmodiumfalciparumisalsoatargetfortransmissionblockingantibodies
‡A
The 230-kDa gamete surface protein of plasmodium falciparum is also a target for transmission-blocking antibodies
‡9
1
|
919
|
|
|
‡a
cultureandpreparationofgametocytesofplasmodiumfalciparumforimmunochemicalmolecularandmosquitoinfectivitystudies
‡A
The culture and preparation of gametocytes of Plasmodium falciparum for immunochemical, molecular, and mosquito infectivity studies
‡9
1
|
919
|
|
|
‡a
cytoadherencelinkedasexualgenefamilyofplasmodiumfalciparumarethererolesotherthancytoadherence
‡A
The cytoadherence linked asexual gene family of Plasmodium falciparum: are there roles other than cytoadherence?
‡9
1
|
919
|
|
|
‡a
distributionofenzymevariationinpopulationsofplasmodiumfalciparuminafrica
‡A
The distribution of enzyme variation in populations of Plasmodium falciparum in Africa
‡9
1
|
919
|
|
|
‡a
reviewinnateresistanceinmalaria
‡A
A review. Innate resistance in malaria
‡9
1
|
919
|
|
|
‡a
randomizeddoubleblindplacebocontrolledclinicaltrialoftheimpactofmalariapreventionontheeducationalattainmentofschoolchildren
‡A
A randomized, double-blind, placebo-controlled, clinical trial of the impact of malaria prevention on the educational attainment of school children
‡9
1
|
919
|
|
|
‡a
impactofrepeatedmalariaattacksontheschoolperformanceofchildren
‡A
The impact of repeated malaria attacks on the school performance of children
‡9
1
|
919
|
|
|
‡a
neglectedburdenofplasmodiumvivaxmalaria
‡A
The neglected burden of Plasmodium vivax malaria
‡9
1
|
919
|
|
|
‡a
gametogenesisinculturebygametocytesofplasmodiumfalciparum
‡A
Gametogenesis in culture by gametocytes of Plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
geneencodingadeubiquitinatingenzymeismutatedinartesunateandchloroquineresistantrodentmalariaparasites
‡A
Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites
‡9
1
|
919
|
|
|
‡a
malariaparasitetoxinassociatedwithplasmodiumvivaxparoxysms
‡A
A malaria parasite toxin associated with Plasmodium vivax paroxysms
‡9
1
|
919
|
|
|
‡a
histidinerichproteingenemarksalinkagegroupfavoredstronglyinageneticcrossofplasmodiumfalciparum
‡A
A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
geneticapproachtothedenovoidentificationoftargetsofstrainspecificimmunityinmalariaparasites
‡A
A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites
‡9
1
|
919
|
|
|
‡a
propertiesofepitopesofpfs4845atargetoftransmissionblockingmonoclonalantibodiesongametesofdifferentisolatesofplasmodiumfalciparum
‡A
Properties of epitopes of pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
geneencodingerythrocytebindingligandlinkedtobloodstagemultiplicationratephenotypeinplasmodiumyoeliiyoelii
‡A
Gene encoding erythrocyte binding ligand linked to blood stage multiplication rate phenotype in Plasmodium yoelii yoelii
‡9
1
|
919
|
|
|
‡a
genesyntenyandchloroquineresistanceinplasmodiumchabaudi
‡A
Gene synteny and chloroquine resistance in Plasmodium chabaudi
‡9
1
|
919
|
|
|
‡a
geneticanalysisofthehumanmalariaparasiteplasmodiumfalciparum
‡A
Genetic analysis of the human malaria parasite plasmodium falciparum
‡9
1
|
919
|
|
|
‡a
humantcellproliferativeresponsestoplasmodiumvivaxantigensevidenceofimmunosuppressionfollowingprolongedexposuretoendemicmalaria
‡A
Human T cell proliferative responses to Plasmodium vivax antigens: evidence of immunosuppression following prolonged exposure to endemic malaria
‡9
1
|
919
|
|
|
‡a
quantitativegenomeresequencingdefinesmultiplemutationsconferringchloroquineresistanceinrodentmalaria
‡A
Quantitative genome re-sequencing defines multiple mutations conferring chloroquine resistance in rodent malaria
‡9
1
|
919
|
|
|
‡a
humanimmuneresponsesagainstsexualstagesofmalariaparasitesconsiderationsformalariavaccines
‡A
Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines
‡9
1
|
919
|
|
|
‡a
geneticdeterminantsofantimalarialacquiredimmunityinalargemulticentrestudy
‡A
Genetic determinants of anti-malarial acquired immunity in a large multi-centre study
‡9
1
|
919
|
|
|
‡a
humanantibodyresponsestopfs230asexualstagespecificsurfaceantigenofplasmodiumfalciparumnonresponsivenessisastablephenotypebutdoesnotappeartobegeneticallyregulated
‡A
Human antibody responses to Pfs 230, a sexual stage-specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated
‡9
1
|
919
|
|
|
‡a
hostheterogeneityisadeterminantofcompetitiveexclusionorcoexistenceingeneticallydiversemalariainfections
‡A
Host heterogeneity is a determinant of competitive exclusion or coexistence in genetically diverse malaria infections.
‡9
1
|
919
|
|
|
‡a
genetichybridsofplasmodiumfalciparumidentifiedbyamplificationofgenomicdnafromsingleoocysts
‡A
Genetic hybrids of Plasmodium falciparum identified by amplification of genomic DNA from single oocysts
‡9
1
|
919
|
|
|
‡a
geneticmappingofvirulenceinrodentmalarias
‡A
Genetic Mapping of Virulence in Rodent Malarias
‡9
1
|
919
|
|
|
‡a
hlaeffectsinmalariaincreasedparasitekillingimmunityorreducedimmunopathology
‡A
HLA effects in malaria: increased parasite-killing immunity or reduced immunopathology?
‡9
1
|
919
|
|
|
‡a
geneticpolymorphismsassociatedwithantimalarialantibodylevelsinalowandunstablemalariatransmissionareainsouthernsrilanka
‡A
Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka
‡9
1
|
919
|
|
|
‡a
highfrequencyofantibodyresponsetoplasmodiumfalciparumgametocyteantigensduringacutemalariainfectionsinpapuanewguineahighlanders
‡A
High Frequency of Antibody Response to Plasmodium falciparum Gametocyte Antigens during Acute Malaria Infections in Papua New Guinea Highlanders
‡9
1
|
943
|
|
|
‡a
197x
‡A
1970
‡9
1
|
943
|
|
|
‡a
196x
‡A
1965
‡9
2
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
BIBSYS|90368508
|
996
|
|
|
‡2
BNC|981058511229206706
|
996
|
|
|
‡2
CAOONL|ncf10375042
|
996
|
|
|
‡2
ISNI|0000000497745518
|
996
|
|
|
‡2
CAOONL|ncf12071590
|
996
|
|
|
‡2
LC|no 97005583
|
996
|
|
|
‡2
BNF|16162074
|
996
|
|
|
‡2
RERO|A003080368
|
996
|
|
|
‡2
NLA|000035856944
|
996
|
|
|
‡2
LC|n 85215844
|
996
|
|
|
‡2
LC|n 2020069020
|
996
|
|
|
‡2
DNB|140123679
|
996
|
|
|
‡2
LC|n 96046044
|
996
|
|
|
‡2
DNB|170611264
|
996
|
|
|
‡2
BNF|17766796
|
996
|
|
|
‡2
ISNI|0000000073747886
|
996
|
|
|
‡2
LC|n 89118232
|
996
|
|
|
‡2
ISNI|0000000032222055
|
996
|
|
|
‡2
CAOONL|ncf13677766
|
996
|
|
|
‡2
NTA|096412836
|
996
|
|
|
‡2
LC|nb2022009955
|
996
|
|
|
‡2
ISNI|0000000394789382
|
996
|
|
|
‡2
SUDOC|190375116
|
996
|
|
|
‡2
BIBSYS|1470399608720
|
996
|
|
|
‡2
LC|n 97035363
|
996
|
|
|
‡2
DNB|1089788282
|
996
|
|
|
‡2
DNB|12864320X
|
996
|
|
|
‡2
LC|nb2008000314
|
996
|
|
|
‡2
LC|no2022121564
|
996
|
|
|
‡2
ISNI|0000000037198605
|
996
|
|
|
‡2
LC|n 86085910
|
996
|
|
|
‡2
BNF|11483626
|
996
|
|
|
‡2
J9U|987007431971105171
|
996
|
|
|
‡2
BNE|XX1786092
|
996
|
|
|
‡2
ISNI|0000000395242426
|
996
|
|
|
‡2
SUDOC|256560625
|
996
|
|
|
‡2
ISNI|0000000424655909
|
996
|
|
|
‡2
BIBSYS|90784424
|
996
|
|
|
‡2
LC|n 83138031
|
996
|
|
|
‡2
ISNI|0000000110839561
|
996
|
|
|
‡2
LC|n 50058666
|
996
|
|
|
‡2
BIBSYS|90658442
|
996
|
|
|
‡2
CAOONL|ncf11281488
|
996
|
|
|
‡2
RERO|A016354561
|
996
|
|
|
‡2
DNB|1171867301
|
996
|
|
|
‡2
BIBSYS|90878137
|
996
|
|
|
‡2
BIBSYS|14024711
|
996
|
|
|
‡2
BIBSYS|8065865
|
996
|
|
|
‡2
NLA|000036343564
|
996
|
|
|
‡2
LC|nr 96029522
|
996
|
|
|
‡2
LC|no2003106011
|
996
|
|
|
‡2
BIBSYS|90225625
|
996
|
|
|
‡2
LC|n 93076067
|
996
|
|
|
‡2
ISNI|0000000048138739
|
996
|
|
|
‡2
LC|no2023028962
|
996
|
|
|
‡2
RERO|A003080218
|
996
|
|
|
‡2
ISNI|0000000046024236
|
996
|
|
|
‡2
NLA|000035856947
|
996
|
|
|
‡2
LC|n 85288341
|
996
|
|
|
‡2
J9U|987007280374905171
|
996
|
|
|
‡2
DNB|1089788290
|
996
|
|
|
‡2
NTA|416797814
|
996
|
|
|
‡2
RERO|A003080375
|
996
|
|
|
‡2
LC|n 2006048354
|
996
|
|
|
‡2
DNB|1089788304
|
996
|
|
|
‡2
J9U|987007316205005171
|
996
|
|
|
‡2
N6I|vtls000368422
|
996
|
|
|
‡2
J9U|987007271122705171
|
996
|
|
|
‡2
BNF|12027381
|
996
|
|
|
‡2
LC|n 88222126
|
996
|
|
|
‡2
LC|n 91800718
|
996
|
|
|
‡2
ISNI|0000000385853186
|
996
|
|
|
‡2
LC|no2013110295
|
996
|
|
|
‡2
LC|n 2013047381
|
996
|
|
|
‡2
LC|n 96046036
|
996
|
|
|
‡2
SUDOC|172467578
|
996
|
|
|
‡2
J9U|987007361397605171
|
996
|
|
|
‡2
J9U|987007328055905171
|
996
|
|
|
‡2
BNF|16108153
|
996
|
|
|
‡2
LC|no2022096029
|
996
|
|
|
‡2
BIBSYS|4058603
|
996
|
|
|
‡2
ISNI|0000000072526993
|
996
|
|
|
‡2
ISNI|0000000069914020
|
996
|
|
|
‡2
BIBSYS|90667113
|
996
|
|
|
‡2
NUKAT|n 2016056552
|
996
|
|
|
‡2
LC|nr2007000135
|
996
|
|
|
‡2
LC|no 98007264
|
996
|
|
|
‡2
CAOONL|ncf11896548
|
996
|
|
|
‡2
LC|no2010035540
|
996
|
|
|
‡2
LC|no2022146463
|
996
|
|
|
‡2
B2Q|0000013128
|
996
|
|
|
‡2
CAOONL|ncf10483948
|
996
|
|
|
‡2
LC|no2018132604
|
996
|
|
|
‡2
ISNI|0000000025260125
|
996
|
|
|
‡2
LC|no2016150680
|
996
|
|
|
‡2
J9U|987007318061605171
|
996
|
|
|
‡2
BIBSYS|90556113
|
996
|
|
|
‡2
SUDOC|157217930
|
996
|
|
|
‡2
ISNI|0000000039177760
|
996
|
|
|
‡2
BNF|16276732
|
996
|
|
|
‡2
LC|no 98093521
|
996
|
|
|
‡2
BNC|981058511394806706
|
996
|
|
|
‡2
SUDOC|198487339
|
996
|
|
|
‡2
NUKAT|n 2009087555
|
996
|
|
|
‡2
ISNI|0000000066089934
|
996
|
|
|
‡2
ISNI|0000000031144593
|
996
|
|
|
‡2
ISNI|0000000052806031
|
996
|
|
|
‡2
PLWABN|9813916940605606
|
996
|
|
|
‡2
NTA|279706367
|
996
|
|
|
‡2
NII|DA02764425
|
996
|
|
|
‡2
ISNI|0000000073270299
|
996
|
|
|
‡2
NYNYRILM|177608
|
996
|
|
|
‡2
LC|no 94027269
|
996
|
|
|
‡2
ISNI|0000000454801102
|
996
|
|
|
‡2
J9U|987007345110305171
|
996
|
|
|
‡2
ISNI|0000000054755645
|
996
|
|
|
‡2
DNB|1260420345
|
996
|
|
|
‡2
LC|n 2003046777
|
996
|
|
|
‡2
LC|no 98029946
|
996
|
|
|
‡2
LC|nr 91010453
|
996
|
|
|
‡2
CAOONL|ncf11190753
|
996
|
|
|
‡2
LC|no2015162321
|
996
|
|
|
‡2
ISNI|0000000066697382
|
996
|
|
|
‡2
CAOONL|ncf10263580
|
996
|
|
|
‡2
BIBSYS|90363498
|
996
|
|
|
‡2
LC|n 87129907
|
996
|
|
|
‡2
ISNI|0000000451254799
|
996
|
|
|
‡2
ISNI|0000000042688377
|
996
|
|
|
‡2
LC|n 87884600
|
996
|
|
|
‡2
LC|n 81079339
|
996
|
|
|
‡2
NKC|ctu20191051888
|
996
|
|
|
‡2
DNB|12679085X
|
996
|
|
|
‡2
NII|DA0696438X
|
996
|
|
|
‡2
ISNI|0000000430715197
|
996
|
|
|
‡2
NTA|400886995
|
996
|
|
|
‡2
NUKAT|n 96301040
|
996
|
|
|
‡2
BIBSYS|90119007
|
996
|
|
|
‡2
NII|DA06453992
|
996
|
|
|
‡2
PTBNP|190653
|
996
|
|
|
‡2
PLWABN|9810699321705606
|
996
|
|
|
‡2
LC|n 86864531
|
996
|
|
|
‡2
LC|n 87861539
|
996
|
|
|
‡2
LC|nr 93044021
|
996
|
|
|
‡2
ISNI|0000000028276245
|
996
|
|
|
‡2
NTA|33974894X
|
996
|
|
|
‡2
LNB|LNC10-000095990
|
996
|
|
|
‡2
J9U|987007356490605171
|
996
|
|
|
‡2
J9U|987012384866505171
|
996
|
|
|
‡2
ISNI|0000000124232250
|
996
|
|
|
‡2
PLWABN|9812033509905606
|
996
|
|
|
‡2
LC|nb2016025274
|
996
|
|
|
‡2
SUDOC|229894577
|
996
|
|
|
‡2
ISNI|0000000042326923
|
996
|
|
|
‡2
SELIBR|215188
|
996
|
|
|
‡2
LC|n 78033635
|
996
|
|
|
‡2
ISNI|0000000095887046
|
996
|
|
|
‡2
BIBSYS|90346529
|
996
|
|
|
‡2
LC|n 81069627
|
996
|
|
|
‡2
LC|n 85356056
|
996
|
|
|
‡2
DNB|105150208X
|
996
|
|
|
‡2
LC|n 80151263
|
996
|
|
|
‡2
LC|n 87825636
|
996
|
|
|
‡2
LC|n 89662929
|
996
|
|
|
‡2
DNB|135373263
|
996
|
|
|
‡2
ISNI|0000000084194391
|
996
|
|
|
‡2
LC|n 2003039494
|
996
|
|
|
‡2
LC|n 85269722
|
996
|
|
|
‡2
BIBSYS|90291041
|
996
|
|
|
‡2
NKC|xx0077733
|
996
|
|
|
‡2
BNF|14971281
|
996
|
|
|
‡2
NTA|097537713
|
996
|
|
|
‡2
LC|n 94065451
|
996
|
|
|
‡2
SUDOC|14267544X
|
996
|
|
|
‡2
NTA|070289360
|
996
|
|
|
‡2
LC|no2021053387
|
996
|
|
|
‡2
LC|n 90620320
|
996
|
|
|
‡2
ISNI|0000000033483935
|
996
|
|
|
‡2
RERO|A014097808
|
996
|
|
|
‡2
BNF|17169376
|
996
|
|
|
‡2
ISNI|0000000030204419
|
996
|
|
|
‡2
JPG|500008494
|
996
|
|
|
‡2
LC|no2014041721
|
996
|
|
|
‡2
ISNI|0000000063300335
|
996
|
|
|
‡2
CAOONL|ncf10291185
|
996
|
|
|
‡2
ISNI|0000000027074019
|
996
|
|
|
‡2
DE633|pe30014033
|
996
|
|
|
‡2
ISNI|0000000032673083
|
996
|
|
|
‡2
NYNYRILM|9994
|
996
|
|
|
‡2
LC|n 2014066783
|
996
|
|
|
‡2
CAOONL|ncf11398859
|
996
|
|
|
‡2
ISNI|0000000081722478
|
996
|
|
|
‡2
RERO|A003080373
|
996
|
|
|
‡2
NLA|000036521424
|
996
|
|
|
‡2
DNB|139937994
|
996
|
|
|
‡2
ISNI|0000000084084723
|
996
|
|
|
‡2
BIBSYS|90237058
|
996
|
|
|
‡2
LC|n 00008470
|
996
|
|
|
‡2
J9U|987007330181605171
|
996
|
|
|
‡2
LIH|LNB:C_b_K4;=BK
|
996
|
|
|
‡2
LC|n 87825640
|
996
|
|
|
‡2
LC|n 82100734
|
996
|
|
|
‡2
ISNI|0000000076462640
|
996
|
|
|
‡2
J9U|987007324732805171
|
996
|
|
|
‡2
NII|DA06013457
|
996
|
|
|
‡2
J9U|987007452454305171
|
996
|
|
|
‡2
LC|n 2024036929
|
996
|
|
|
‡2
CAOONL|ncf10020190
|
996
|
|
|
‡2
DNB|1022653229
|
996
|
|
|
‡2
SUDOC|092638716
|
996
|
|
|
‡2
BNF|12569166
|
996
|
|
|
‡2
SUDOC|07883600X
|
996
|
|
|
‡2
DNB|114358176
|
996
|
|
|
‡2
CAOONL|ncf11038143
|
996
|
|
|
‡2
NUKAT|n 2013061526
|
996
|
|
|
‡2
LC|n 88606373
|
996
|
|
|
‡2
J9U|987007441877505171
|
996
|
|
|
‡2
J9U|987007327679905171
|
996
|
|
|
‡2
ISNI|0000000496512114
|
996
|
|
|
‡2
RERO|A003080366
|
996
|
|
|
‡2
NII|DA07194426
|
996
|
|
|
‡2
ISNI|0000000051046245
|
996
|
|
|
‡2
ISNI|0000000048070391
|
996
|
|
|
‡2
J9U|987007324440705171
|
996
|
|
|
‡2
LC|no2016163476
|
996
|
|
|
‡2
SUDOC|115509844
|
996
|
|
|
‡2
RERO|A003080369
|
996
|
|
|
‡2
ISNI|0000000067292432
|
996
|
|
|
‡2
ISNI|0000000000191848
|
996
|
|
|
‡2
NII|DA05081247
|
996
|
|
|
‡2
ISNI|0000000070992181
|
996
|
|
|
‡2
ISNI|0000000075614331
|
996
|
|
|
‡2
ISNI|0000000067282082
|
996
|
|
|
‡2
CAOONL|ncf10263860
|
996
|
|
|
‡2
ISNI|0000000078714995
|
996
|
|
|
‡2
JPG|500271112
|
996
|
|
|
‡2
CAOONL|ncf10477198
|
996
|
|
|
‡2
LC|no2011034881
|
996
|
|
|
‡2
CAOONL|ncf10003375
|
996
|
|
|
‡2
J9U|987007459617805171
|
996
|
|
|
‡2
LC|n 89225568
|
996
|
|
|
‡2
ISNI|0000000036418901
|
996
|
|
|
‡2
LC|nb2013019328
|
996
|
|
|
‡2
DNB|172016428
|
996
|
|
|
‡2
LC|n 87938755
|
996
|
|
|
‡2
PTBNP|193933
|
996
|
|
|
‡2
ISNI|0000000041726714
|
996
|
|
|
‡2
NUKAT|n 2011030553
|
996
|
|
|
‡2
ISNI|0000000032259229
|
996
|
|
|
‡2
LC|no2014009919
|
996
|
|
|
‡2
SUDOC|035000597
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|